Back to BCRX
MACKENZIE FINANCIAL CORP → BCRX
MACKENZIE FINANCIAL CORP BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$3.2M
Q3 2026
Peak value
$3.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $982K |
| Q4 2025 | $1.2M |
| Q1 2026 | $2.3M |
| Q2 2026 | $3.5M |
| Q3 2026 | $3.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.2M | 386.7K | — | — |
| Q2 2026 | $3.5M | 347.3K | — | — |
| Q1 2026 | $2.3M | 243.4K | — | — |
| Q4 2025 | $1.2M | 150.7K | — | — |
| Q3 2025 | $982K | 129.3K | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M